GTPase NRas (55-64)

GTPase NRas (55-64) is a synthetic peptide fragment corresponding to amino acids 55 through 64 of the NRas protein, a member of the Ras family of small GTPases. NRas plays a critical role in cell signaling pathways that regulate proliferation, differentiation, and survival, making it a key focus in studies of intracellular signaling and oncogenic transformation. The 55-64 region of NRas is of particular interest due to its involvement in effector interactions and conformational dynamics essential for GTPase function. As a research-use peptide, this fragment serves as a valuable tool for elucidating the molecular mechanisms underlying NRas-mediated signal transduction and for supporting the development of targeted biochemical assays.

Signal transduction research: The NRas (55-64) peptide is frequently utilized in studies investigating the molecular details of Ras-mediated signaling pathways. By mimicking a specific segment of the NRas protein, it enables researchers to dissect the sequence-specific interactions between NRas and its downstream effectors or regulatory proteins. Such studies are fundamental to understanding how point mutations or post-translational modifications within this region influence the activation and propagation of signaling cascades, particularly those implicated in oncogenesis and cellular response to external stimuli.

Protein-protein interaction assays: This peptide fragment serves as a precise probe for mapping the binding interfaces between NRas and its interacting partners. Researchers employ it in in vitro binding studies, such as surface plasmon resonance, fluorescence polarization, or pull-down assays, to quantify the affinity and specificity of protein-protein interactions involving the 55-64 region. These applications are essential for characterizing the structural determinants of NRas function and for validating potential inhibitors that target critical contact sites within the Ras signaling network.

Antibody generation and epitope mapping: The defined sequence of NRas (55-64) provides an ideal antigenic determinant for the production of sequence-specific antibodies. Such antibodies are invaluable tools for detecting endogenous or exogenous NRas in immunoblotting, immunoprecipitation, or immunofluorescence applications. Additionally, the peptide can be used in epitope mapping experiments to precisely localize antibody binding sites, thereby supporting the development and validation of high-specificity reagents for research and diagnostic purposes.

Peptide competition and inhibition studies: Synthetic NRas (55-64) is employed in competitive binding or inhibition assays to probe the functional relevance of the 55-64 region in cellular and biochemical contexts. By introducing the peptide into experimental systems, researchers can competitively inhibit endogenous NRas interactions, providing insights into the contribution of this segment to overall GTPase activity and signaling fidelity. Such approaches are instrumental for validating mechanistic hypotheses and for the preclinical evaluation of novel molecular inhibitors.

Structural and conformational analysis: The availability of the NRas (55-64) peptide facilitates detailed biophysical studies aimed at characterizing the secondary structure, conformational flexibility, and dynamic properties of this critical protein segment. Techniques such as circular dichroism spectroscopy, NMR, or molecular dynamics simulations are commonly used in conjunction with the peptide to elucidate the structural basis of NRas function and its modulation by mutations or interacting molecules. These insights contribute to a more comprehensive understanding of Ras family GTPase biology and inform rational design strategies in chemical biology and drug discovery.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines